MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image PRIME MEDICINE
PRIME MEDICINE

PRIME MEDICINE

Summary

Prime Medicine is a developer of novel gene-editing technology solutions intended for curing genetic disorders.

Deals Overview

Total Deals1
Valued Deals1
Total Value£ 227 M
Avg. Deal Size£ 227 M

Market Context

Sort

13 Jul 2021|United States|Biotechnology
Prime Medicine
T. Rowe Price Group

Target: PRIME MEDICINE

Bidder: T. ROWE PRICE GROUP INC

14 Service Providers

3 Target | 11 Bidder

17 Dealmakers

6 Target | 11 Bidder

£ 227 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite